{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:56:17Z","timestamp":1793321777770,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s11102-022-01225-z","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T08:03:59Z","timestamp":1652429039000},"page":"760-763","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Growth hormone (GH) deficiency and GH replacement therapy in patients previously treated for Cushing\u2019s disease"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7285-7941","authenticated-orcid":false,"given":"Cesar Luiz","family":"Boguszewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,13]]},"reference":[{"issue":"7","key":"1225_CR1","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","volume":"4","author":"R Pivonello","year":"2016","unstructured":"Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BM, Colao A (2016) Complications of Cushing\u2019s syndrome: state of the art. Lancet Diabetes Endocrinol 4(7):611\u2013629","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"1225_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.beem.2017.03.002","volume":"31","author":"AM Formenti","year":"2017","unstructured":"Formenti AM, Maffezzoni F, Doga M, Mazziotti G, Giustina A (2017) Growth hormone deficiency in treated acromegaly and active Cushing\u2019s syndrome. Best Pract Res Clin Endocrinol Metab 31(1):79\u201390","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"1225_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrendo.2013.5","volume":"9","author":"G Mazziotti","year":"2013","unstructured":"Mazziotti G, Giustina A (2013) Glucocorticoids and the regulation of growth hormone secretion. Nat Rev Endocrinol 9(5):265\u2013276","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"1225_CR4","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR, Boguszewski CL, Bronstein MD, Buchfelder M, Carmichael JD, Casanueva FF, Castinetti F, Chanson P, Findling J, Gadelha M, Geer EB, Giustina A, Grossman A, Gurnell M, Ho K, Ioachimescu AG, Kaiser UB, Karavitaki N, Katznelson L, Kelly DF, Lacroix A, McCormack A, Melmed S, Molitch M, Mortini P, Newell-Price J, Nieman L, Pereira AM, Petersenn S, Pivonello R, Raff H, Reincke M, Salvatori R, Scaroni C, Shimon I, Stratakis CA, Swearingen B, Tabarin A, Takahashi Y, Theodoropoulou M, Tsagarakis S, Valassi E, Varlamov EV, Vila G, Wass J, Webb SM, Zatelli MC, Biller BMK (2021) Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol 9(12):847\u2013875","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"1225_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1046\/j.1365-2265.2004.01976.x","volume":"60","author":"M Tzanela","year":"2004","unstructured":"Tzanela M, Karavitaki N, Stylianidou C, Tsagarakis S, Thalassinos NC (2004) Assessment of GH reserve before and after successful treatment of adult patients with Cushing\u2019s syndrome. Clin Endocrinol (Oxford) 60(3):309\u2013314","journal-title":"Clin Endocrinol (Oxford)"},{"issue":"1","key":"1225_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1530\/eje.0.1460067","volume":"146","author":"U Feldt-Rasmussen","year":"2002","unstructured":"Feldt-Rasmussen U, Abs R, Bengtsson BA, Bennmarker H, Bramnert M, Hernberg-St\u00e5hl E, Monson JP, Westberg B, Wilton P, W\u00fcster C, KIMS (2002) International study board of KIMS study group growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing\u2019s disease. Eur J Endocrinol 146(1):67\u201374","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1225_CR7","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1210\/jc.2009-0806","volume":"95","author":"SM Webb","year":"2010","unstructured":"Webb SM, Mo D, Lamberts SW, Melmed S, Cavagnini F, Giraldi FP, Strasburger CJ, Zimmermann AG, Woodmansee WW (2010) International HypoCCS advisory board metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous Cushing\u2019s disease or non-functioning pituitary adenoma. J Clin Endocrinol Metab 95(2):630\u2013638","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1225_CR8","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1530\/EJE-09-0836","volume":"162","author":"C H\u00f6ybye","year":"2010","unstructured":"H\u00f6ybye C, Ragnarsson O, J\u00f6nsson PJ, Koltowska-H\u00e4ggstr\u00f6m M, Trainer P, Feldt-Rasmussen U, Biller BM (2010) Clinical features of GH deficiency and effects of 3 years of GH replacement in adults with controlled Cushing\u2019s disease. Eur J Endocrinol 162(4):677\u2013684","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1225_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1046\/j.1365-2265.2003.01922.x","volume":"60","author":"PV Carroll","year":"2004","unstructured":"Carroll PV, Monson JP, Grossman AB, Besser GM, Plowman PN, Afshar F, Savage MO (2004) Successful treatment of childhood-onset Cushing\u2019s disease is associated with persistent reduction in growth hormone secretion. Clin Endocrinol (Oxford) 60(2):169\u2013174","journal-title":"Clin Endocrinol (Oxford)"},{"issue":"1","key":"1225_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1046\/j.1365-2265.1999.00738.x","volume":"51","author":"NR Hughes","year":"1999","unstructured":"Hughes NR, Lissett CA, Shalet SM (1999) Growth hormone status following treatment for Cushing\u2019s syndrome. Clin Endocrinol (Oxford) 51(1):61\u201366","journal-title":"Clin Endocrinol (Oxford)"},{"issue":"2","key":"1225_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1530\/eje.1.02329","volume":"156","author":"FP Giraldi","year":"2007","unstructured":"Giraldi FP, Andrioli M, De Marinis L, Bianchi A, Giampietro A, De Martin M, Sacco E, Scacchi M, Pontecorvi A, Cavagnini F (2007) Significant GH deficiency after long-term cure by surgery in adult patients with Cushing\u2019s disease. Eur J Endocrinol 156(2):233\u2013239","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"1225_CR12","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/j.1365-2265.2004.02004.x","volume":"60","author":"A Mukherjee","year":"2004","unstructured":"Mukherjee A, Murray RD, Teasdale GM, Shalet SM (2004) Acquired prolactin deficiency (APD) after treatment for Cushing\u2019s disease is a reliable marker of irreversible severe GHD but does not reflect disease status. Clin Endocrinol (Oxford) 60(4):476\u2013483","journal-title":"Clin Endocrinol (Oxford)"},{"issue":"11","key":"1225_CR13","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.4158\/GL-2019-0405","volume":"25","author":"KCJ Yuen","year":"2019","unstructured":"Yuen KCJ, Biller BMK, Radovick S, Carmichael JD, Jasim S, Pantalone KM, Hoffman AR (2019) American association of clinical endocrinologists and american college of endocrinology guidelines for management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care. Endocr Pract 25(11):1191\u20131232","journal-title":"Endocr Pract"},{"issue":"4","key":"1225_CR14","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1530\/EJE-11-0942","volume":"166","author":"O Ragnarsson","year":"2012","unstructured":"Ragnarsson O, H\u00f6ybye C, J\u00f6nsson PJ, Feldt-Rasmussen U, Johannsson G, Biller BM, Koltowska-H\u00e4ggstr\u00f6m M (2012) Comorbidity and cardiovascular risk factors in adult GH deficiency following treatment for Cushing\u2019s disease or non-functioning pituitary adenomas during childhood. Eur J Endocrinol 166(4):593\u2013600","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"1225_CR15","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1365-2265.2005.02244.x","volume":"62","author":"JH Davies","year":"2005","unstructured":"Davies JH, Storr HL, Davies K, Monson JP, Besser GM, Afshar F, Plowman PN, Grossman AB, Savage MO (2005) Final adult height and body mass index after cure of paediatric Cushing\u2019s disease. Clin Endocrinol (Oxford) 62(4):466\u2013472","journal-title":"Clin Endocrinol (Oxford)"},{"issue":"6","key":"1225_CR16","first-page":"257","volume":"66","author":"A Colson","year":"2006","unstructured":"Colson A, Brooke AM, Walker D, Besser GM, Chew SL, Grossman AB, Jenkins PJ, Drake WM, Monson JP (2006) Growth hormone deficiency and replacement in patients with treated Cushing\u2019s disease, prolactinomas and non-functioning pituitary adenomas: effects on body composition, glucose metabolism, lipid status and bone mineral density. Horm Res 66(6):257\u2013267","journal-title":"Horm Res"},{"issue":"5","key":"1225_CR17","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.1365-2265.2004.02018.x","volume":"60","author":"G Johannsson","year":"2004","unstructured":"Johannsson G, Sunnerhagen KS, Svensson J (2004) Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing\u2019s disease. Clin Endocrinol (Oxford) 60(5):550\u2013559","journal-title":"Clin Endocrinol (Oxford)"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-022-01225-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-022-01225-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-022-01225-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T09:24:20Z","timestamp":1666430660000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-022-01225-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,13]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1225"],"URL":"https:\/\/doi.org\/10.1007\/s11102-022-01225-z","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,13]]},"assertion":[{"value":"15 April 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}